Here is a summary of the major analyst research calls from today. **Upgrades** HSBC upgraded Block to Buy with a $77 target, citing improved earnings estimates after Q4 results. Arete double upgraded Palo Alto Networks to Buy ($185 target), arguing that the structural deceleration fears are overdone. BofA moved Unity to Neutral, suggesting the weak Q1 guidance has reset expectations enough to reduce risk. Morgan Stanley upgraded Novo Nordisk to Equal Weight following the recent selloff. **Downgrades** Baird cut MongoDB to Neutral and dropped the price target to $260. While Q4 was decent, Atlas revenue growth missed expectations. Mizuho downgraded uniQure to Neutral due to lower confidence in the regulatory path for their Huntington's program. RBC downgraded Select Medical after they agreed to be acquired for $16.50 per share. Barclays cut Mosaic to Equal Weight due to rising input costs from geopolitical tensions. **Initiations** RBC started coverage on Iqvia, Ormat, and Medpace with Outperform ratings. Oppenheimer initiated Once Upon a Farm with an Outperform rating, seeing it as a strong small-cap growth story.